tradingkey.logo

Wellgistics rises on collaboration with Protega Pharmaceuticals

ReutersMar 4, 2025 1:40 PM

Shares of New Jersey-based drug distributor Wellgistics Health WGRX.O rise 9.3% to $2.95 premarket

Company announces it is collaborating with Protega Pharmaceuticals to increase patient access to Protega's opioid, Roxybond

Roxybond is indicated for managing severe pain when other treatments are insufficient

WGRX has fallen 29% since its debut on February 21

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI